Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bevacizumab|DRUG: Paclitaxel
Sponsor: Hellenic Oncology Research Group
Collaborators: University Hospital of Crete